Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 5/20 | 0.61 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.59 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.39 |
| ▸ | PI4KA | P42356 | 4/20 | 0.36 |
| ▸ | PI4K2B | Q8TCG2 | 4/20 | 0.36 |
| ▸ | PI4K2A | Q9BTU6 | 4/20 | 0.36 |
| ▸ | PI4KB | Q9UBF8 | 4/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.36 |
| ▸ | KDR | P35968 | 6/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | XDH | P47989 | 1/20 | 0.35 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | TEK | Q02763 | 1/20 | 0.35 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23365318 | 0.81 | ADORA2A (0.43) | ADORA2AADORA1 | |
| SCHEMBL18076190 | 0.77 | ADORA2A (0.56) | ADORA2AADORA1LIMK1PI4KAPI4K2B | |
| SCHEMBL946620 | 0.77 | ADORA2A (0.56) | ADORA2AADORA1LIMK1PI4KAPI4K2B | |
| SCHEMBL24393386 | 0.77 | ADORA2A (0.41) | ADORA2AADORA1ADORA2BPIK3CDLMNA | |
| SCHEMBL5355348 | 0.75 | ADORA2A (0.40) | ADORA2AADORA1ADORA2BPIK3CDLMNA | |
| SCHEMBL15942468 | 0.75 | ADORA2A (0.55) | ADORA2AADORA1LIMK1PI4KAPI4K2B | |
| SCHEMBL7040284 | 0.75 | ADORA2A (0.40) | ADORA2AADORA1ADORA2BPIK3CDLMNA | |
| SCHEMBL946072 | 0.75 | ADORA2A (0.55) | ADORA2AADORA1LIMK1PI4KAPI4K2B | |
| SCHEMBL12699730 | 0.75 | ADORA2A (0.55) | ADORA2AADORA1LIMK1PI4KAPI4K2B | |
| SCHEMBL2414858 | 0.75 | ADORA2A (0.40) | ADORA2AADORA1ADORA2BPIK3CDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 19539 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-12630827-B2 | Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies | ROGCON, INC. (US) | 2026-05-19 | — | — | US | claimed |
| US-20260098287-A1 | METHOD AND KIT FOR REGENERATING REUSABLE INITIATORS FOR NUCLEIC ACID SYNTHESIS | CHENG-YAO CHEN (TW) | 2026-04-09 | — | — | US | claimed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-20250345406-A1 | CHIMERIC PROTEINS IN AUTOIMMUNITY | SHATTUCK LABS INC (US) | 2025-11-13 | — | — | US | claimed |
| US-20250325494-A1 | COMPOSITION FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACID | THEMEDIUM THERAPEUTICS CO., LTD. (CN) | 2025-10-23 | — | — | US | claimed |
| EP-4634380-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4630009-A1 | ANTISENSE RNA (ASRNA) TECHNOLOGY AND USE THEREOF | 1Globe Health Institute LLC (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4630008-A1 | SHORT DUPLEX RNA WITH INTERSPERSED DEOXYRIBONUCLEOTIDES AS A GENE SILENCING TECHNOLOGY AND USE THEREOF | 1Globe Health Institute LLC (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4630010-A1 | ASYMMETRIC SHORT DUPLEX RNA WITH INTERSPERSED DEOXYRIBONUCLEOTIDES AS A GENE SILENCING TECHNOLOGY AND USE THEREOF | 1Globe Health Institute LLC (US) | 2025-10-15 | — | — | EP | claimed |
| US-20020119570-A1 | Targeted gene correction by single-stranded oligodeoxynucleotides | THOMAS JEFFERSON UNIVERSITY | 2002-08-29 | — | — | US | claimed |
| WO-2002026967-A2 | TARGETED GENE CORRECTION BY SINGLE-STRANDED OLIGODEOXYNUCLEOTIDES | THOMAS JEFFERSON UNIVERSITY (US) | 2002-04-04 | — | — | WO | claimed |
| EP-0646648-B1 | Method for producing polypeptide | SUMITOMO CHEMICAL CO (JP) | 2002-01-30 | — | — | EP | claimed |
| EP-0739898-B1 | Phosphonomonoester nucleic acids, methods for their preparation and their use | AVENTIS PHARMA GMBH (DE) | 2001-09-26 | — | — | EP | claimed |
| US-5874553-A | ANTIBODIES; INHIBITOR OF GENE EXPRESSION | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-02-23 | — | — | US | claimed |
| US-5643744-A | CONDENSATION OF AMINO ACID AND A NUCLEIC ACID ADAPTER IN PRESENCE OF RIBOSOMES AND AROMATIC TERTIARY AMINE BUT NO ENERGY SOURCE SUCH AS ATP OR GTP | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-07-01 | — | — | US | claimed |
| EP-0739898-A2 | Phosphonomonoester nucleic acids, methods for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-10-30 | — | — | EP | claimed |
| US-5434257-A | Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages | GILEAD SCIENCES, INC. (US) | 1995-07-18 | — | — | US | claimed |
| WO-1995011911-A1 | BINDING COMPETENT OLIGOMERS CONTAINING UNSATURATED 3',5' AND 2',5' LINKAGES | GLAXO WELLCOME INC. (US) | 1995-05-04 | — | — | WO | claimed |
| EP-0646648-A1 | Method for producing polypeptide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-04-05 | — | — | EP | claimed |